Renal cell carcinoma: focus on safety and efficacy of temsirolimus
{{output}}
Metastatic renal cell carcinoma has harboured a poor prognosis for decades with immunotherapy being the only available therapy with high toxicity and modest effect. Dependance of renal cell carcinoma oncogenesis on the mTOR pathway has led to clinical developm... ...
